{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:40:57Z","timestamp":1740807657925,"version":"3.38.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,28]]},"DOI":"10.7759\/cureus.79826","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T16:25:46Z","timestamp":1740759946000},"source":"Crossref","is-referenced-by-count":0,"title":["Concurrent Psoriatic Arthritis and Ankylosing Spondylitis in a Middle-Aged Man: A Case Report With Peripheral Joint Functional and Quality of Life Assessment"],"prefix":"10.7759","author":[{"given":"Aswath R","family":"Deepa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameena A","family":"Jaleel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anish","family":"Ancil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samson","family":"Debbarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasyoh","family":"Thampi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.06.006","article-title":"Axial involvement in psoriatic arthritis: an update for rheumatologists","volume":"51","author":"Poddubnyy D","year":"2021","unstructured":"Poddubnyy D, Jadon DR, Van den Bosch F, Mease PJ, Gladman DD. Axial involvement in psoriatic arthritis: an update for rheumatologists. Semin Arthritis Rheum. 2021, 51:880-7. 10.1016\/j.semarthrit.2021.06.006","journal-title":"Semin Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin CT","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017, 376:957-70. 10.1056\/NEJMra1505557","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-225531","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","volume":"83","author":"Gossec L","year":"2024","unstructured":"Gossec L, Kerschbaumer A, Ferreira RJ, et al.. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis. 2024, 83:706-19. 10.1136\/ard-2024-225531","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez383","article-title":"Treatment guidelines in psoriatic arthritis","volume":"59","author":"Ogdie A","year":"2020","unstructured":"Ogdie A, Coates LC, Gladman DD. Treatment guidelines in psoriatic arthritis. Rheumatology (Oxford). 2020, 59:i37-46. 10.1093\/rheumatology\/kez383","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","article-title":"How do axial SpA & PsA with axial involvement differ?","author":"Shapiro SC","year":"2022","unstructured":"Shapiro SC. How do axial SpA & PsA with axial involvement differ?. Am Coll Rheumatol. 2022,","journal-title":"Am Coll Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0191-y","article-title":"Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis","volume":"74","author":"Mease PJ","year":"2014","unstructured":"Mease PJ, Armstrong AW. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs. 2014, 74:423-41. 10.1007\/s40265-014-0191-y","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032318","article-title":"Classification and diagnostic criteria for psoriatic arthritis","volume":"64","author":"Helliwell PS","year":"2005","unstructured":"Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis. 2005, 64:ii3-8. 10.1136\/ard.2004.032318","journal-title":"Ann Rheum Dis"},{"key":"ref8","article-title":"Nail disease in psoriatic arthritis: imaging and clinical implications","volume":"39","author":"McGonagle D","year":"2021","unstructured":"McGonagle D, Ash ZR. Nail disease in psoriatic arthritis: imaging and clinical implications. Clin Exp Rheumatol. 2021, 39:622-7.","journal-title":"Clin Exp Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit M","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, et al.. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009, 68:777-83. 10.1136\/ard.2009.108233","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor W","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006, 54:2665-73. 10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez457","article-title":"Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?","volume":"59","author":"Feld J","year":"2020","unstructured":"Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, Gladman DD. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?. Rheumatology (Oxford). 2020, 59:1340-6. 10.1093\/rheumatology\/kez457","journal-title":"Rheumatology (Oxford)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209853","article-title":"Axial disease in psoriatic arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis","volume":"76","author":"Jadon DR","year":"2017","unstructured":"Jadon DR, Sengupta R, Nightingale A, et al.. Axial disease in psoriatic arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis. 2017, 76:701-7. 10.1136\/annrheumdis-2016-209853","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0640-3","article-title":"Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype","volume":"17","author":"FitzGerald O","year":"2015","unstructured":"FitzGerald O, Haroon M, Giles JT, Winchester R. Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther. 2015, 17:115. 10.1186\/s13075-015-0640-3","journal-title":"Arthritis Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208642","article-title":"Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group","volume":"75","author":"Lambert RG","year":"2016","unstructured":"Lambert RG, Bakker PA, van der Heijde D, et al.. Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis. 2016, 75:1958-63. 10.1136\/annrheumdis-2015-208642","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.02.002","article-title":"Dactylitis: a hallmark of psoriatic arthritis","volume":"48","author":"Kaeley GS","year":"2018","unstructured":"Kaeley GS, Eder L, Aydin SZ, Gutierrez M, Bakewell C. Dactylitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum. 2018, 48:263-73. 10.1016\/j.semarthrit.2018.02.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic I","year":"2010","unstructured":"Solovic I, Sester M, Gomez-Reino JJ, et al.. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J. 2010, 36:1185-206. 10.1183\/09031936.00028510","journal-title":"Eur Respir J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","year":"2005","unstructured":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax. 2005, 60.800-5. 10.1136\/thx.2005.046797","journal-title":"Thorax"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun J","year":"2002","unstructured":"Braun J, Brandt J, Listing J, et al.. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 2002, 359:1187-93. 10.1016\/s0140-6736(02)08215-6","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.045658","article-title":"The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year","volume":"65","author":"Kavanaugh A","year":"2006","unstructured":"Kavanaugh A, Antoni CE, Gladman D, et al.. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Ann Rheum Dis. 2006, 65:1038-43. 10.1136\/ard.2005.045658","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/art.39573","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates LC","year":"2016","unstructured":"Coates LC, Kavanaugh A, Mease PJ, et al.. Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016, 68:1060-71. 10.1002\/art.39573","journal-title":"Arthritis Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412679","article-title":"Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis","volume":"373","author":"Mease PJ","year":"2015","unstructured":"Mease PJ, McInnes IB, Kirkham B, et al.. Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis. N Engl J Med. 2015, 373:1329-39. 10.1056\/NEJMoa1412679","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/art.40728","article-title":"Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis","volume":"71","author":"Deodhar A","year":"2019","unstructured":"Deodhar A, Gensler LS, Sieper J, et al.. Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis. Arthritis Rheumatol. 2019, 71:258-70. 10.1002\/art.40728","journal-title":"Arthritis Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/319177-concurrent-psoriatic-arthritis-and-ankylosing-spondylitis-in-a-middle-aged-man-a-case-report-with-peripheral-joint-functional-and-quality-of-life-assessment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T16:25:48Z","timestamp":1740759948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/319177-concurrent-psoriatic-arthritis-and-ankylosing-spondylitis-in-a-middle-aged-man-a-case-report-with-peripheral-joint-functional-and-quality-of-life-assessment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.79826","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}